Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion

Kwok-ming Ho; Ed Litton

doi:10.1111/j.1537-2995.2011.03505.x

Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion

Kwok-ming Ho, Ed Litton

School of Population and Global Health

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Original language	English
Pages (from-to)	1696-1702
Journal	Transfusion
Volume	52
DOIs	https://doi.org/10.1111/j.1537-2995.2011.03505.x
Publication status	Published - 2012

Access to Document

10.1111/j.1537-2995.2011.03505.x

Cite this

@article{867f91bd1425492bba66ac0449292791,

title = "Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion",

author = "Kwok-ming Ho and Ed Litton",

year = "2012",

doi = "10.1111/j.1537-2995.2011.03505.x",

language = "English",

volume = "52",

pages = "1696--1702",

journal = "Transfusion",

issn = "0041-1132",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion

AU - Ho, Kwok-ming

AU - Litton, Ed

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1537-2995.2011.03505.x

DO - 10.1111/j.1537-2995.2011.03505.x

M3 - Article

C2 - 22211634

SN - 0041-1132

VL - 52

SP - 1696

EP - 1702

JO - Transfusion

JF - Transfusion

ER -